India’s Virchow Biotech to make Russia’s Sputnik V vaccine in India

Moscow: Russia’s RDIF sovereign wealth fund said on Monday it had reached an agreement with India’s Virchow Biotech to produce up to 200 million doses a year of the Sputnik V vaccine in India.

###

RDIF said full-scale commercial production would start after completing the transfer of technology in the second quarter.

###

The announcement follows similar deals with Indian pharmaceutical firms Gland Pharma, Stelis Biopharma and Hetero.

###

“Virchow’s proven capabilities in large-scale drug substance manufacturing should help meet the global demand for this vaccine,” Dr. Tummuru Murali, Managing Director of Virchow Biotech, said in a statement issued by RDIF.

###

India, the world’s largest vaccine maker, has become one of the biggest producers of the Sputnik V shot outside Russia.

###

Other countries producing it include Brazil, China and South Korea.

###

Dr Reddy’s Laboratories Ltd, which has run small clinical studies of Sputnik V in India, sought emergency-use approval for the vaccine last month, but India’s drug regulator asked for more data from the Sputnik V developers.

Click Here: qld maroons jersey

Leave A Comment

Leave a Reply

Your email address will not be published. Required fields are marked *